GlassScriptPhysician profile
Omar Batal
NPI 1760656151
$1,070.35
in general payments reported to CMS, 2019-2025
8 companies · $95.13 in 2025
The $95.13 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $399 · 2022: $329 · 2023: $153 · 2024: $94.41 · 2025: $95.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $710.28 | 2020-2022 | |
| Boston Scientific Corporation | $153.44 | 2023 | Watchman Access System, Watchman Flx |
| Irhythm Technologies, INC. | $61.20 | 2024 | Zio Monitor, Zio Xt Patch |
| Abbott Laboratories | $48.41 | 2025 | Xience Skypoint, Diamondback Coronary |
| E.R. Squibb & Sons, L.L.C. | $35.27 | 2020-2024 | Camzyos |
| Siemens Medical Solutions USA, INC. | $25.40 | 2025 | Naeotom Alpha |
| Actelion Pharmaceuticals US, INC. | $21.32 | 2025 | Uptravi, Opsumit |
| Pfizer INC. | $15.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Batal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.